Clinical trial
Tolerance of an Extensively Hydrolyzed Protein Infant Formula Versus a Premature Infant Formula
NCT01987154 is registered in ClinicalTrials.gov with Mead Johnson Nutrition as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tolerance of an Extensively Hydrolyzed Protein Infant Formula Versus a Premature Infant Formula
- Lead sponsor
- Mead Johnson Nutrition
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 28, 2014
- Completion date
- March 31, 2016
- Enrollment
- 61 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
feeding intolerance